Table of Contents x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-33414 ...

Thanks, Barry and good morning, everyone. As Rich indicated earlier, I'd like to provide some color on what we are doing to improve our operational efficiencies after new business has been onboarded. Today, that is primarily related to our Biomed business where the opportunity is greatest. Going forward, when it's time for annual inventory and preventative means, the work will be more organized and will have even greater familiarity with each site that has already been matched with one of our regional techn ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 (S ...

InfuSystem Holdings, Inc. (NYSE:INFU) Q2 2023 Earnings Conference Call August 3, 2023 9:00 AM ET Joe Dorame - Managing Partner Richard DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Aaron Wukmir - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Hello, and welcome to the InfuSystem Holdings, Inc. Second Quarter 2023 Financial Results Conference Call. All participants will be in ...

for the quarterly period ended March 31, 2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (I.R.S. Employer Identification No.) 3851 West Hamlin Road Rochester Hills, Michigan 48309 (Address of Principal Executive Offices) Registrant's Telephone Number, including Area Code: (248) 291-1210 | Securities Registered Pursuant to Section 12(b) of the Act: | | | | --- | - ...

Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Barry Steele - CFO Carrie Lachance - President and Chief Operating Officer Conference Call Participants InfuSystem Holdings Inc. (NYSE:INFU) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Brooks O'Neil - Lake Street Capital Markets Alexander Nowak - Craig-Hallum Capital Group James Sidoti - Sidoti & Company At this time, I would like to turn the conference over to Joe Dorame, Managing Partner. Please go ahead. Joe Dorame Good morning, and thank ...

Company Participants Conference Call Participants Operator I would now like to turn the conference over to Mr. Joe Dorame. Please go ahead, sir. Good morning, and thanks for joining us today to review InfuSystem Holdings' financial results for the fourth quarter and full year 2022 ended December 31, 2022. Before we begin with prepared remarks, I would like to remind everyone certain statements made by the management team of InfuSystem during this conference call constitute forward-looking statements within ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K _____________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________________ Commission File Number: 001-35020 ______________________ ...

InfuSystem Holdings Inc. (NYSE:INFU) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Rich DiIorio - CEO Barry Steele - CFO Cary Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports Third Quarter Fisc ...

Enabling Continuity of Care for Patients, From the Clinic to Their Home Investor Presentation SEPTEMBER 8, 2022 l (NYSE American: INFU) Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statements Certain statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives an ...